Comments
Drug firm Divi’s Laboratories today said its consolidated net profit rose by 23.81 per cent to Rs 216.91 crore for the fourth quarter ended December 31, 2012, on account of robust sales during the quarter.
The company had posted a net profit of Rs 175.19 crore during the same period of previous fiscal.
Net sales rose to Rs 718.04 crore for the fourth quarter, as compared to Rs 479.11 crore during the same period previous financial year.
For the financial year ended March 31, 2012, the company posted a net profit of Rs 533.26 crore against Rs 429.27 crore during 2010-11. Net sales for the year ended March 31, 2012 rose to Rs 1,858.59 crore, compared to Rs 1,310.33 crore during 2010-11.
The company’s board, which met today, recommended a dividend of Rs 13 per share of Rs 2 each for the year ended March 31, 2012.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.